| ¿µ¹® | hypophysis, pituitary | ÇÑ±Û | ³úÇϼöü |
|---|---|---|---|
| ¼³¸í | ³ú¹Ù´ÚºÎ¿¡ ÀÖÀ¸¸ç Å;îŰ¾ÈÀå¿¡ À§Ä¡ÇÏ´Â ÀÌÁß±â¿øÀÇ »óÇǼº ¼Òü. Áß¿äÇÑ ³»ºÐºñ Àå±â Áß ÇϳªÀÌ´Ù. Àü¿±, Áß¿±, ÈÄ¿±ÀÇ ¼¼ ºÎºÐÀ¸·Î ÀÌ·ç¾îÁ® ÀÖ°í, ´Ù¸¥ ³»ºÐºñ¼±ÀÇ È°µ¿À» Áö¹èÇϴ ȣ¸£¸óÀ» ºÐºñÇϸç, »ý½Ä°ú ¹ßÀ°¿¡ ¹ÐÁ¢ÇÑ °ü°è°¡ ÀÖ´Ù. |
||
| ¿µ¹® | obesity | ÇÑ±Û | ºñ¸¸Áõ |
|---|---|---|---|
| ¼³¸í | ½Åü¿¡ Áö¹æÀÌ °úÀ×À¸·Î ÃàÀûµÇ¾î °ñ°Ý»ó ¹× À°Ã¼»ó ¿ä±¸ÀÇ ÇѰè ÀÌ»óÀ¸·Î üÁßÀÌ Áõ°¡µÈ »óÅÂÀÌ´Ù. ±×·¯³ª üÁö¹æÀÇ ÃøÁ¤Àº ½±Áö ¾Ê±â ¶§¹®¿¡ ¼öºÐ·ù³ª ±ÙÀ°Áõ°¡ÀÇ °æ¿ì¸¦ »©°í, ÀϹÝÀûÀ¸·Î´Â üÁßÁõ°¡¿Í µ¿ÀǾî·Î »ý°¢µÇ¾î Ç¥ÁØÃ¼Áß(ÀÌ»óüÁß)À» 10~20% ³Ñ´Â °æ¿ì¸¦ ºñ¸¸À̶ó Á¤ÀÇÇÑ´Ù. Èí¼ö Ä®·Î¸®°¡ ¼Òºñ Ä®·Î¸®¸¦ ³ÑÀ» ¶§´Â ±× Â÷¸¦ Áß¼ºÁö¹æÀ¸·Î ÇØ¼ Áö¹æ¼¼Æ÷¿¡ ÃàÀûµÇ¾îÁö´Â °á°ú üÁö¹æÀÌ Áõ°¡ÇÑ´Ù. Äí½ÌÁõÈıº, ½Ã»óÇϺμջó µî¿¡µµ ºñ¸¸ÀÌ ³ªÅ¸³´Ù. ºñ¸¸, ƯÈ÷ º¹ºÎ ºñ¸¸Àº ¿©·¯ Áúȯ, ƯÈ÷ ¼ºÀκ´À̶ó°í ÇÏ´Â ÁúȯÀÇ ¹ß»ý°ú °ü·ÃÀÌ ÀÖ´Â °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ´Ù. ºñ¸¸µµÀÇ Æò°¡¿¡´Â üÁßÀ» ÃøÁ¤ÇÏ´Â ¹æ¹ý, ÇǺÎÁÖ¸§µÎ²² ÃøÁ¤¹ý(͏®ÆÛ¸¦ »ç¿ë)ÀÌ ÀÖ´Ù. ºñ¸¸µµ Áö¼ö¸¦ Æò°¡ÇÏ´Â ÀÓ»óÀûÀÎ ¹æ¹ý¿¡´Â ÀÌ»óüÁß¹ý(modified Broca's method)À¸·Î °¡Àå ½±°Ô »ç¿ëÇÏ´Â ¹æ¹ýÀ̸ç [½ÅÀå(cm)£100]¡¿0.9¸¦ ÀÌ»óüÁßÀ¸·Î °è»êÇÏ¿© ÇöÀçüÁßÀ» ¹éºÐÀ²È½ÃŲ ¹æ¹ýÀÌ´Ù. ºñ¸¸µµ = (½ÇÃøÃ¼ÁߣǥÁØÃ¼Áß)/Ç¥ÁØÃ¼Áß¡¿100%·Î °è»êÇÑ´Ù. ºñ¸¸ÀÇ ¿øÀÎÀ¸·Î´Â À¯ÀüÀû ¿äÀÎ, ȯ°æÀû ¿äÀÎ, ¿¡³ÊÁö ´ë»çÀÇ ÀÌ»ó µîÀÌ ÀÖ´Ù. ºñ¸¸ÀÇ Á¾·ù¿¡´Â ¿øÀο¡ µû¶ó¼, ´Ü¼ø ºñ¸¸°ú ÁõÈļº ºñ¸¸À¸·Î ºÐ·ùÇÒ ¼ö ÀÖ´Ù. ´Ü¼ø ºñ¸¸Àº °ú½Ä°ú ¿îµ¿ ºÎÁ·ÀÌ ±× ¿øÀÎÀ̸ç, ÁõÈļº ºñ¸¸Àº ³»ºÐºñ, ½Ã»óÇϺμº, À¯Àü ¹× ´ë»ç¼º µîÀ¸·Î ¹ß»ýÇÑ´Ù. |
||
| COI | Central Obesity Index; certificate of insurance; cost of illness |
|---|---|
| HHHO | hypotonia, hypomentia, hypogonadism, obesity [syndrome] |
| MO | macroorchidism; manually operated; Master of Obstetrics; Master of Osteopathy; medical officer; mesi... |
| MOMO | macrosomia-obesity-macrocephaly-ocular abnormalities [syndrome] |
| OB | obese [mouse]; obese, obesity; objective benefit; obliterative bronchiolitis; obstetrics, obstetrici... |
| DIO | Diet-induced obesity |
|---|---|
| OHS | Obesity Hypoventilation Syndrome |
| %OB | obesity |
| AP | Anterior pituitary |
| APs | Anterior pituitary glands |
| anti-obesity agents | Agents that increase energy expenditure and weight loss by neural and chemical regulation. Beta-adrenergic agents and serotoninergic drugs have been experimentally used in patients with non-insulin dependent diabetes mellitus (niddm) to treat obesity. (12 Dec 1998) |
|---|---|
| central obesity | The deposition of obesity around the trunk sparing the limbs. (27 Sep 1997) |
| risks, obesity-related | Obesity increases the risk of developing a number of diseases including: type 2 (adult-onset) diabetes high blood pressure (hypertension) stroke (cerebrovascular accident or cva) heart attack (myocardial infarction or mi) heart failure (congestive heart failure) cancer (only certain forms such as prostate and colon cancer) gallstones and gall bladder disease (cholecystitis) gout and gouty arthritis osteoarthritis (degenerative arthritis) of the knees, hips, and the lower back sleep apnea (failure to breath normally during sleep, lowering blood oxygen) pickwickian syndrome (obesity, red face, underventilation, and drowsiness) (12 Dec 1998) |
| morbid obesity | Obesity sufficient to prevent normal activity or physiologic function, or to cause the onset of a pathologic condition. Simple obesity, obesity resulting when caloric intake exceeds energy expenditure. (05 Mar 2000) |
| hypothalamic obesity with hypogonadism | A disorder characterised primarily by obesity and hypogonadotrophic hypogonadism in adolescent boys; dwarfism is rare, and when present is thought to reflect hypothyroidism. Visual loss, behavioural abnormalities, and diabetes insipidus may occur. Frohlich's syndrome often is used synonymously for this disorder, although the original case involved a pituitary tumour; most cases are thought to result from hypothalamic dysfunction in areas regulating appetite and gonadal development. The most common causes are pituitary and hypothalamic neoplasms. Synonym: adiposis orchica, adiposogenital degeneration, adiposogenital dystrophy, adiposogenital syndrome, hypophysial syndrome, hypothalamic obesity with hypogonadism. Origin: L. Fr. G. Dys-, bad, + trophe, nourishment (05 Mar 2000) |
| diseases, obesity-related | Obesity increases the risk of developing a number of diseases including: Type 2 (adult-onset) diabetes High blood pressure (hypertension) Stroke (cerebrovascular accident or CVA) Heart attack (myocardial infarction or MI) Heart failure (congestive heart failure) Cancer (only certain forms such as prostate and colon cancer) Gallstones and gall bladder disease (cholecystitis) Gout and gouty arthritis Osteoarthritis (degenerative arthritis) of the knees, hips, and the lower back Sleep apnea (failure to breath normally during sleep, lowering blood oxygen) Pickwickian syndrome (obesity, red face, underventilation, and drowsiness). (12 Dec 1998) |
| obesity | <clinical sign> An increase in body weight beyond the limitation of skeletal and physical requirement, as the result of an excessive accumulation of fat in the body. Origin: L. Obesus = fat (18 Nov 1997) |
| obesity index | Body weight divided by body volume. (05 Mar 2000) |
| obesity, morbid | The condition of weighing two, three, or more times the ideal weight, so called because it is associated with many serious and life-threatening disorders. (12 Dec 1998) |
| obesity-related diseases | Obesity increases the risk of developing a number of diseases including: type 2 (adult-onset) diabetes high blood pressure (hypertension) stroke (cerebrovascular accident or cva) heart attack (myocardial infarction or mi) heart failure (congestive heart failure) cancer (only certain forms such as prostate and colon cancer) gallstones and gall bladder disease (cholecystitis) gout and gouty arthritis osteoarthritis (degenerative arthritis) of the knees, hips, and the lower back sleep apnea (failure to breath normally during sleep, lowering blood oxygen) pickwickian syndrome (obesity, red face, underventilation, and drowsiness). (12 Dec 1998) |
| anterior pituitary gonadotropin | Any gonadotropin of hypophysial origin; formerly used to designate a single hormone, because it was thought that the anterior hypophysis secreted only one gonadotropin. Synonym: pituitary gonadotropic hormone. (05 Mar 2000) |
| anterior pituitary-like hormone | A glycoprotein with a carbohydrate fraction composed of d-galactose and hexosamine, extracted from the urine of pregnant women and produced by the placental trophoblastic cells; its most important role appears to be stimulation, during the first trimester, of ovarian secretion of the oestrogen and progesterone required for the integrity of conceptus; it appears to play no significant role in the last two trimesters of pregnancy, as the oestrogen and progesterone are then formed by the placenta. Synonym: anterior pituitary-like hormone, choriogonadotropin, chorionic gonadotropic hormone, chorionic gonadotrophic hormone, placenta gonadotropin, placentagonadotropin. (05 Mar 2000) |
| receptors, pituitary hormone | Cell surface proteins that bind pituitary hormones with high affinity and trigger intracellular changes influencing the behaviour of cells. Since many pituitary hormones are also released by neurons as neurotransmitters, these receptors are also found in the nervous system. (12 Dec 1998) |
| receptors, pituitary hormone-regulating hormone | Cell surface receptors that bind the hypothalamic hormones regulating pituitary cell differentiation, proliferation, and hormone synthesis and release, including the pituitary-releasing and release-inhibiting hormones. The pituitary hormone-regulating hormones are also released by cells other than hypothalamic neurons, and their receptors also occur on non-pituitary cells, especially brain neurons, where their role is less well understood. Receptors for dopamine, which is a prolactin release-inhibiting hormone as well as a common neurotransmitter, are not included here. (12 Dec 1998) |
| pharyngeal pituitary | The embryonic remnant of the oral end of Rathke's pouch that is cut off from the adenohypophysis by the developing sphenoid bone; composed chiefly of chromophobes and, under normal conditions, considered physiologically inactive. See: hypophysis. (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|